Obesity, heart and kidney diseases, and diabetes are all connected, and now that the American Heart Association has formalized CKM syndrome, it could change the future of cardiology.
The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern helps patients explore its benefits and risks.
Patients with kidney disease and living donors face new challenges in the wake of COVID-19. Get answers to pre- and post-transplant FAQs in this MedBlog.
When patients are diagnosed with stage 4 kidney cancer, they have only a 1-in-10 chance of survival. At UT Southwestern’s Kidney Cancer Program, the odds are substantially higher.
Hans Hammers, M.D., Ph.D. /
James Brugarolas, M.D., Ph.D.
